Most people regain a large share of the weight after they stop a GLP-1. In the clinical trials, participants who came off semaglutide regained about two-thirds of their lost weight within a year.1 That regain is biological: the drug suppresses appetite while it is in your system, and that effect ends when you stop.
This post covers what actually happens in your body when you quit a GLP-1 like semaglutide or tirzepatide, what the trial data shows about weight regain, and how a medically supervised program plans for the off-ramp instead of pretending it does not exist.
The Quick Answer
When you stop a GLP-1 receptor agonist, the appetite suppression and slowed digestion fade within weeks, and hunger returns to its prior level. Research suggests most people regain a significant portion of lost weight: in the STEP 1 trial extension, participants regained about two-thirds of their weight loss one year after stopping semaglutide.1 Continuing treatment, tapering slowly, and protecting muscle with protein and resistance training all influence how much weight returns. Obesity is a chronic condition, so the realistic question is what your long-term maintenance plan looks like.
What a GLP-1 actually does while you take it
GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It tells your brain you are full, slows how fast your stomach empties, and helps your body manage blood sugar. Semaglutide mimics this hormone. Tirzepatide goes further as a dual GIP and GLP-1 receptor agonist, acting on two gut hormone pathways at once.
While the medication is active, appetite drops, portions shrink without much effort, and food noise quiets down. That is the mechanism behind the results. In the STEP 1 trial, adults on weekly semaglutide lost an average of 14.9% of their body weight over 68 weeks.2 In SURMOUNT-1, participants on the highest dose of tirzepatide lost an average of 22.5% over 72 weeks.3
Here is the part that matters for stopping: the effect lasts as long as the medication is in your system. Take it away and the biology underneath does not stay rewired.
What changes when you stop
Within a few weeks of your last dose, the GLP-1 clears from your body and its effects fade. Three things tend to follow.
Hunger returns
Appetite climbs back toward where it was before you started. The fullness signal weakens, your stomach empties at its normal pace again, and food noise often comes back. Many people describe feeling hungrier than they expected, which makes the prior eating pattern easy to slip into.
Your body defends the lost weight
After weight loss, the body lowers its resting energy use and shifts appetite hormones in a direction that encourages eating, a response sometimes called metabolic adaptation.4 This is a survival mechanism, and it does not switch off when you reach your goal. Without the medication countering it, that biology pushes weight back up.
Blood sugar and other markers can drift back
Improvements in blood sugar, blood pressure, and cholesterol that came with treatment tend to move back toward baseline after withdrawal. The STEP 1 extension found that most cardiometabolic improvements reverted within a year of stopping semaglutide.1
What the trials show about weight regain
The withdrawal data is some of the clearest evidence we have, because these came from controlled trials rather than anecdotes.
| Trial | What was tested | What happened |
|---|---|---|
| STEP 1 extension (semaglutide) | Stopped the drug after 68 weeks | Regained about two-thirds of lost weight within one year1 |
| STEP 4 (semaglutide) | Continued vs switched to placebo at week 20 | Continued group kept losing to 17.4% total; placebo group regained about 6.9%5 |
| SURMOUNT-4 (tirzepatide) | Continued vs switched to placebo at week 36 | Continued group reached 25.3% loss by week 88; nearly 90% kept most of their loss, vs about 17% on placebo6 |
The pattern is consistent across both drugs. Stay on treatment and the weight loss holds or deepens. Stop abruptly with no plan and a meaningful share of it returns. In SURMOUNT-4, most participants who came off tirzepatide regained more than a quarter of their lost weight within a year.6
Why the weight comes back
It comes back because obesity is a chronic condition that needs ongoing management. A GLP-1 manages it the way blood pressure medication manages hypertension. Few people expect their blood pressure to stay fixed after they quit the pill, and the same logic applies here.
When the appetite suppression ends and metabolic adaptation is still pushing in the other direction, the deck is stacked toward regain. That is biology at work. It also explains why the off-ramp deserves as much planning as the start.
How to come off a GLP-1 more safely
There are real reasons to stop or pause, including cost, side effects, pregnancy planning, or reaching a goal you want to try to hold. Stopping is a medical decision, and how you do it matters. A few principles, all best handled with a provider rather than on your own.
Taper instead of quitting cold
Stepping the dose down gradually, rather than dropping it all at once, may give your appetite and habits more time to adjust. Discuss the schedule with your provider.
Lock in habits before you taper
The eating, protein, and training routines that carry you through maintenance are easier to build while the medication is still helping. Use that window.
Protect your muscle
Rapid GLP-1 weight loss can include lean muscle, and studies show a portion of the weight lost may come from lean mass.7 Muscle drives your resting metabolism, so losing it makes regain more likely. Adequate protein and resistance training are the two things that protect it. More on that in how to protect muscle on a GLP-1.
Track body composition, not just the scale
A monthly body composition scan shows whether you are holding muscle and losing fat, which the bathroom scale cannot tell you.
Plan your maintenance dose early
For many people the long-term answer is a lower maintenance dose rather than quitting entirely. That is a conversation to have before you reach your goal, not after the weight starts returning.
How Defiant plans for maintenance
A GLP-1 protocol at Defiant is built around your biology, and that includes what happens after you hit your goal. Every program starts with a free consultation, a lab review (we write the order; you complete the draw at your PCP or through Rythm Health), and a 3D body composition scan that sets your baseline.
From there, the differentiator is bi-weekly titration. Adjusting your dose every two weeks, rather than monthly, lets us move at the pace your body tolerates on the way up and on the way down. When you reach your goal, that same control makes it possible to find a maintenance dose or taper carefully instead of stopping cold. Britt, our trainer, designs GLP-1 muscle-preservation programs so the lean mass you keep keeps working for your metabolism. Custom protocols start at $295 per month, and that price includes both the medication and the medical oversight behind it.
We are based at 5100 Lincoln Ave in Lisle, serving Naperville, Downers Grove, Wheaton, and Chicago's western suburbs.
- Most people regain a large share of lost weight after stopping a GLP-1. In the STEP 1 extension, participants regained about two-thirds of their weight loss within a year of stopping semaglutide.
- The regain is biological. Appetite returns, the body defends lost weight through metabolic adaptation, and improvements in blood sugar and other markers drift back toward baseline.
- Withdrawal trials for both semaglutide (STEP 4) and tirzepatide (SURMOUNT-4) show that continuing treatment maintains weight loss while switching to placebo brings weight back.
- Obesity is a chronic condition, so the practical question is your long-term maintenance plan.
- Tapering gradually, locking in habits early, protecting muscle with protein and resistance training, and tracking body composition all influence how much weight returns.
- A maintenance dose is often a better long-term option than stopping entirely, and that is a decision to make with a provider.
Common Questions
Plan the Whole Journey. Maintenance Included.
A GLP-1 works best with a plan for what comes after. Start with a free consultation, a body composition baseline, and a protocol built around your labs, your goals, and your long-term maintenance.
Keep Reading
Last updated June 16, 2026.
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022. PubMed (Diabetes Obes Metab)
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021. NEJM (STEP 1)
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022. NEJM (SURMOUNT-1)
- Greenway FL. Physiological adaptations to weight loss and factors favouring weight regain. International Journal of Obesity. 2015. PubMed (Int J Obes)
- Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021. JAMA (STEP 4)
- Aronne LJ, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024. JAMA (SURMOUNT-4)
- Sargeant JA, Henson J, King JA, et al. A Review of the Effects of GLP-1 Receptor Agonists and SGLT2 Inhibitors on Lean Body Mass in Humans. Endocrinol Metab (Seoul). 2019;34(3):247-262. PubMed (Endocrinol Metab)